4 ms·
I’m sitting on the fence. In this case, they were very, very marginally over the allowed levels, and it was essentially down to a bug in the standard, which whe
by madaxe_again 7y ago
I’m sitting on the fence. In this case, they were very, very marginally over the allowed levels, and it was essentially down to a bug in the standard, which when implemented in software allowed a product to qualify for an exemption when it shouldn’t have. In this particular case the lead is all pretty well away from where the device comes in contact with the body, so the health risk is pretty minimal.
It’s still in the “shouldn’t have happened” category, and the manufacturer in question reported themselves, and steps have already been taken to prevent a recurrence, and similar potential bugs have been identified and addressed.
It’s tough. There is a lot of political opposition from bad or amoral players to any regulation. They’re faced with the choice of voluntarily opening themselves up to fierce criticism over a, in the grand scheme of things, minor issue, or sweeping it well under the carpet, learning from it, and moving on, and spreading their reach for regulation and enforcement.
It’s a trolley car problem if I’ve ever encountered one, and I am not confident that I could make a good call.
- dannyw 7y agoIf something actually poses limited to no risk (e.g. marginally over a limit, which should have a level of tolerance built into it anyway); then it doesn't sound like that big of a deal.
- acheron 7y agoand spreading their reach for regulation and enforcement. And after all, this is the most important thing for a regulatory agency.